Surgical sealant film specialist, Tissuemed Ltd. has won the Medilink North of England Export Achievement Award. In winning this award, Tissuemed has automatically been nominated for the Medilink UK National Healthcare Business Awards, which will take place at the Med Tech Innovation Expo in Birmingham in April.
Tissuemed has seen constant export sales success over the past 4 years, with significant growth coming from China, following Tissuemed obtaining Chinese regulatory approval (CFDA) for the TissuePatch™ Product Range in 2016
According to Medilink, “the Leeds-based business specialises in the development, manufacture and worldwide sales of a unique surgical sealant technology. Export sales increased by 75 per cent last year, with particularly strong growth in China and Brazil.”
Peter Maver, Tissuemed’s Managing Director, received the award on behalf of the company from Mr Kevin Kiely, CEO, Medilink North of England at the recent Medilink North of England Healthcare Business Awards 2020 dinner held at the Lowry Hotel, Manchester.
Peter said; “All at Tissuemed are extremely proud to have won this prestigious award. It is a tribute to our entire team and recognition of all the hard work that is being put in to grow the business internationally. The export growth promises much for the future as clinicians around the world see the value that our sealant film technology has to offer and their patients see the added benefits in their recovery.”